{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T15:14:15Z","timestamp":1771859655967,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Liver fibrosis (LF) is a progressive pathological process that may lead to cirrhosis and liver failure. Human ion channel genes (HICGs) participate in hepatic mechanotransduction and immune regulation, but their contributions to LF remain insufficiently characterized. This study aimed to profile the expression of HICGs in LF and to identify key genes with diagnostic and therapeutic relevance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Multiple transcriptomic datasets were integrated to identify differentially expressed HICGs in LF. Weighted gene co-expression network analysis and single-cell RNA sequencing were applied to identify fibrosis-associated gene modules and cell-type distribution. Functional enrichment and immune infiltration analyses were performed to explore biological relevance. The expression of key genes was validated in human cirrhotic tissues and bile duct ligation mouse models using immunohistochemistry. Potential therapeutic compounds targeting hub HICGs were predicted through molecular docking simulations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Three HICGs\u2014\n                      <jats:italic>AQP1<\/jats:italic>\n                      ,\n                      <jats:italic>GJA1<\/jats:italic>\n                      , and\n                      <jats:italic>KCNN2<\/jats:italic>\n                      \u2014were identified as fibrosis-associated hub genes, showing distinct expression patterns and high diagnostic performance.\n                      <jats:italic>GJA1<\/jats:italic>\n                      showed consistent upregulation in both experimental models and human cirrhosis. Functional analyses linked these genes to extracellular matrix remodeling, cell adhesion, and cytokine interactions, while immune infiltration analysis revealed significant associations with M0 macrophages, plasma cells, NK cells, and memory B cells. Molecular docking simulations further identified 16 candidate drugs targeting KCNN2 and GJA1.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study demonstrates that\n                      <jats:italic>AQP1<\/jats:italic>\n                      ,\n                      <jats:italic>GJA1<\/jats:italic>\n                      , and\n                      <jats:italic>KCNN2<\/jats:italic>\n                      are closely associated with LF progression and immune remodeling. The consistent upregulation of\n                      <jats:italic>GJA1<\/jats:italic>\n                      , together with the identification of candidate drug interactions, provides potential avenues for biomarker development and therapeutic repurposing in LF.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-07856-1","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T11:07:22Z","timestamp":1771240042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ion channel gene signature for diagnosis and antifibrotic therapy in liver fibrosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Yun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duoer","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusheng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongkui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4838-9342","authenticated-orcid":false,"given":"Jianguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"7856_CR1","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.31884","volume":"74","author":"SW Biggins","year":"2021","unstructured":"Biggins SW, Angeli P, Garcia-Tsao G, Gin\u00e8s P, Ling SC, Nadim MK, et al. Diagnosis, Evaluation, and management of Ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American association for the study of liver diseases. Hepatology. 2021;74:1014\u201348. https:\/\/doi.org\/10.1002\/hep.31884.","journal-title":"Hepatology"},{"key":"7856_CR2","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.7150\/thno.86103","volume":"13","author":"S Luo","year":"2023","unstructured":"Luo S, Zhao X, Jiang J, Deng B, Liu S, Xu H, et al. Piezo1 specific deletion in macrophage protects the progression of liver fibrosis in mice. Theranostics. 2023;13:5418\u201334. https:\/\/doi.org\/10.7150\/thno.86103.","journal-title":"Theranostics"},{"key":"7856_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151\u201366. https:\/\/doi.org\/10.1038\/s41575-020-00372-7.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7856_CR4","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1016\/j.febslet.2007.04.008","volume":"581","author":"S Pandey","year":"2007","unstructured":"Pandey S, Zhang W, Assmann SM. Roles of ion channels and transporters in guard cell signal transduction. FEBS Lett. 2007;581:2325\u201336. https:\/\/doi.org\/10.1016\/j.febslet.2007.04.008.","journal-title":"FEBS Lett"},{"key":"7856_CR5","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1158\/1535-7163.MCT-19-0929","volume":"19","author":"T Takayasu","year":"2020","unstructured":"Takayasu T, Kurisu K, Esquenazi Y, Ballester LY. Ion channels and their role in the pathophysiology of gliomas. Mol Cancer Ther. 2020;19:1959\u201369. https:\/\/doi.org\/10.1158\/1535-7163.MCT-19-0929.","journal-title":"Mol Cancer Ther"},{"key":"7856_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/epd2.20046","volume":"25","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Hao N, Sander JW, Lin X, Xiong W, Zhou D. KCNH2 variants in a family with epilepsy and long QT syndrome: A case report and literature review. Epileptic Disord. 2023;25:492\u20139. https:\/\/doi.org\/10.1002\/epd2.20046.","journal-title":"Epileptic Disord"},{"key":"7856_CR7","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1186\/s40001-025-03230-x","volume":"30","author":"Y Wahba","year":"2025","unstructured":"Wahba Y, Shahin D, El-Gilany A-H, Yahia S, El-Tantawy N, Khodair M, et al. Association of GABRG2 gene polymorphisms with idiopathic generalized epilepsy in Egyptian children: a case-control study. Eur J Med Res. 2025;30:1020. https:\/\/doi.org\/10.1186\/s40001-025-03230-x.","journal-title":"Eur J Med Res"},{"key":"7856_CR8","doi-asserted-by":"publisher","unstructured":"RobinsonM, Wettschurack K, Halurkar MS, Chen X, Zhang Z, Zhang J, et al. Precision medicine for sodium channelopathy-related autism and epilepsy. Trends Mol Med. 2025;S1471\u20134914. https:\/\/doi.org\/10.1016\/j.molmed.2025.09.007","DOI":"10.1016\/j.molmed.2025.09.007"},{"key":"7856_CR9","doi-asserted-by":"publisher","first-page":"9390","DOI":"10.3390\/ijms26199390","volume":"26","author":"KA Dvornikova","year":"2025","unstructured":"Dvornikova KA, Platonova ON, Bystrova EY. The role of TRP channels in colitis and inflammatory bowel disease: A systematic review. Int J Mol Sci. 2025;26:9390. https:\/\/doi.org\/10.3390\/ijms26199390.","journal-title":"Int J Mol Sci"},{"key":"7856_CR10","doi-asserted-by":"publisher","first-page":"C2091","DOI":"10.1152\/ajpcell.00564.2025","volume":"329","author":"W Wilczak","year":"2025","unstructured":"Wilczak W, Schleinhege R, Loescher CM, Schwab A, Peth\u0151 Z. A tough job: ion channels, transporters, and pumps during organ fibrosis. Am J Physiol Cell Physiol. 2025;329:C2091\u2013111. https:\/\/doi.org\/10.1152\/ajpcell.00564.2025.","journal-title":"Am J Physiol Cell Physiol"},{"key":"7856_CR11","doi-asserted-by":"publisher","first-page":"eadj3289","DOI":"10.1126\/sciadv.adj3289","volume":"10","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang J, Zhang J, Wang Y, Wang Y, Kang H, et al. Stiffness sensing via Piezo1 enhances macrophage efferocytosis and promotes the resolution of liver fibrosis. Sci Adv. 2024;10:eadj3289. https:\/\/doi.org\/10.1126\/sciadv.adj3289.","journal-title":"Sci Adv"},{"key":"7856_CR12","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jhep.2022.12.031","volume":"78","author":"L Tao","year":"2023","unstructured":"Tao L, Yang G, Sun T, Tao J, Zhu C, Yu H, et al. Capsaicin receptor TRPV1 maintains quiescence of hepatic stellate cells in the liver via recruitment of SARM1. J Hepatol. 2023;78:805\u201319. https:\/\/doi.org\/10.1016\/j.jhep.2022.12.031.","journal-title":"J Hepatol"},{"key":"7856_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3892\/ijmm.2025.5540","volume":"55","author":"Y Hu","year":"2025","unstructured":"Hu Y, Tuo B. The function of chloride channels in digestive system disease (Review). Int J Mol Med. 2025;55:99. https:\/\/doi.org\/10.3892\/ijmm.2025.5540.","journal-title":"Int J Mol Med"},{"key":"7856_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00795-013-0048-6","volume":"47","author":"H Iguchi","year":"2014","unstructured":"Iguchi H, Oda M, Yamazaki H, Yoshimura K, Ando W, Yokomori H. Aquaporin-1 is associated with arterial capillary proliferation and hepatic sinusoidal transformation contributing to portal hypertension in primary biliary cirrhosis. Med Mol Morphol. 2014;47:90\u20139. https:\/\/doi.org\/10.1007\/s00795-013-0048-6.","journal-title":"Med Mol Morphol"},{"key":"7856_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-94-024-1057-0_8","volume":"969","author":"S Zhu","year":"2017","unstructured":"Zhu S, Ran J, Yang B, Mei Z. Aquaporins in digestive system. Adv Exp Med Biol. 2017;969:123\u201330. https:\/\/doi.org\/10.1007\/978-94-024-1057-0_8.","journal-title":"Adv Exp Med Biol"},{"key":"7856_CR16","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. 2013;41:D991\u2013995. https:\/\/doi.org\/10.1093\/nar\/gks1193.","journal-title":"Nucleic Acids Res"},{"key":"7856_CR17","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo M, Shin J, Kim J, Ryall KA, Lee K, Lee S, et al. DSigDB: drug signatures database for gene set analysis. Bioinformatics. 2015;31:3069\u201371. https:\/\/doi.org\/10.1093\/bioinformatics\/btv313.","journal-title":"Bioinformatics"},{"key":"7856_CR18","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yang X, Gan J, Chen S, Xiao Z-X, Cao Y. CB-Dock2: improved protein-ligand blind Docking by integrating cavity detection, Docking and homologous template fitting. Nucleic Acids Res. 2022;50:W159\u201364. https:\/\/doi.org\/10.1093\/nar\/gkac394.","journal-title":"Nucleic Acids Res"},{"key":"7856_CR19","doi-asserted-by":"publisher","first-page":"bbac087","DOI":"10.1093\/bib\/bbac087","volume":"23","author":"X Yang","year":"2022","unstructured":"Yang X, Liu Y, Gan J, Xiao Z-X, Cao Y. FitDock: protein-ligand Docking by template fitting. Brief Bioinform. 2022;23:bbac087. https:\/\/doi.org\/10.1093\/bib\/bbac087.","journal-title":"Brief Bioinform"},{"key":"7856_CR20","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41418-024-01322-5","volume":"31","author":"Y Deng","year":"2024","unstructured":"Deng Y, Lu L, Zhu D, Zhang H, Fu Y, Tan Y, et al. MafG\/MYH9-LCN2 axis promotes liver fibrosis through inhibiting ferroptosis of hepatic stellate cells. Cell Death Differ. 2024;31:1127\u201339. https:\/\/doi.org\/10.1038\/s41418-024-01322-5.","journal-title":"Cell Death Differ"},{"key":"7856_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41419-024-06595-9","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang X, Liu N, Liu R, Zhang W, Chen L, et al. RNF166 promotes colorectal cancer progression by recognizing and destabilizing poly-ADP-ribosylated Angiomotins. Cell Death Dis. 2024;15:211. https:\/\/doi.org\/10.1038\/s41419-024-06595-9.","journal-title":"Cell Death Dis"},{"key":"7856_CR22","doi-asserted-by":"publisher","first-page":"102695","DOI":"10.1016\/j.omtn.2025.102695","volume":"36","author":"J Liu","year":"2025","unstructured":"Liu J, Wang X, He F, Chen X, Yi X. Mechanosensitive calcium ion channels Piezo1: A therapeutic target in liver disease. Mol Ther Nucleic Acids. 2025;36:102695. https:\/\/doi.org\/10.1016\/j.omtn.2025.102695.","journal-title":"Mol Ther Nucleic Acids"},{"key":"7856_CR23","doi-asserted-by":"publisher","first-page":"12133","DOI":"10.3390\/ijms252212133","volume":"25","author":"M Khalil","year":"2024","unstructured":"Khalil M, Gena P, Di Ciaula A, Portincasa P, Calamita G. Aquaporins in biliary function: pathophysiological implications and therapeutic targeting. Int J Mol Sci. 2024;25:12133. https:\/\/doi.org\/10.3390\/ijms252212133.","journal-title":"Int J Mol Sci"},{"key":"7856_CR24","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/gt.2014.78","volume":"21","author":"J Marrone","year":"2014","unstructured":"Marrone J, Lehmann GL, Soria LR, Pellegrino JM, Molinas S, Marinelli RA. Adenoviral transfer of human aquaporin-1 gene to rat liver improves bile flow in estrogen-induced cholestasis. Gene Ther. 2014;21:1058\u201364. https:\/\/doi.org\/10.1038\/gt.2014.78.","journal-title":"Gene Ther"},{"key":"7856_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.biochi.2019.07.027","volume":"165","author":"J Marrone","year":"2019","unstructured":"Marrone J, Tocchetti GN, Danielli M, Mottino AD, Marinelli RA. Improved hepatic MRP2\/ABCC2 transport activity in LPS-induced cholestasis by aquaporin-1 gene transfer. Biochimie. 2019;165:179\u201382. https:\/\/doi.org\/10.1016\/j.biochi.2019.07.027.","journal-title":"Biochimie"},{"key":"7856_CR26","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/iub.1689","volume":"69","author":"J Marrone","year":"2017","unstructured":"Marrone J, Danielli M, Gaspari CI, Marinelli RA. Adenovirus-mediated human aquaporin-1 expression in hepatocytes improves lipopolysaccharide-induced cholestasis. IUBMB Life. 2017;69:978\u201384. https:\/\/doi.org\/10.1002\/iub.1689.","journal-title":"IUBMB Life"},{"key":"7856_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00795-013-0039-7","volume":"46","author":"H Iguchi","year":"2013","unstructured":"Iguchi H, Oda M, Yamazaki H, Yokomori H. Participation of aquaporin-1 in vascular changes and remodeling in cirrhotic liver. Med Mol Morphol. 2013;46:123\u201332. https:\/\/doi.org\/10.1007\/s00795-013-0039-7.","journal-title":"Med Mol Morphol"},{"key":"7856_CR28","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.3892\/ol.2017.7106","volume":"14","author":"L-M Luo","year":"2017","unstructured":"Luo L-M, Xia H, Shi R, Zeng J, Liu X-R, Wei M. The association between aquaporin-1 expression, microvessel density and the clinicopathological features of hepatocellular carcinoma. Oncol Lett. 2017;14:7077\u201384. https:\/\/doi.org\/10.3892\/ol.2017.7106.","journal-title":"Oncol Lett"},{"key":"7856_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1152\/physrev.00024.2001","volume":"82","author":"S Nielsen","year":"2002","unstructured":"Nielsen S, Fr\u00f8kiaer J, Marples D, Kwon T-H, Agre P, Knepper MA. Aquaporins in the kidney: from molecules to medicine. Physiol Rev. 2002;82:205\u201344. https:\/\/doi.org\/10.1152\/physrev.00024.2001.","journal-title":"Physiol Rev"},{"key":"7856_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/excr.1994.1170","volume":"213","author":"M Zhang","year":"1994","unstructured":"Zhang M, Thorgeirsson SS. Modulation of connexins during differentiation of oval cells into hepatocytes. Exp Cell Res. 1994;213:37\u201342. https:\/\/doi.org\/10.1006\/excr.1994.1170.","journal-title":"Exp Cell Res"},{"key":"7856_CR31","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jhep.2013.01.023","volume":"58","author":"V Balasubramaniyan","year":"2013","unstructured":"Balasubramaniyan V, Dhar DK, Warner AE, Vivien Li W-Y, Amiri AF, Bright B, et al. Importance of Connexin-43 based gap junction in cirrhosis and acute-on-chronic liver failure. J Hepatol. 2013;58:1194\u2013200. https:\/\/doi.org\/10.1016\/j.jhep.2013.01.023.","journal-title":"J Hepatol"},{"key":"7856_CR32","doi-asserted-by":"publisher","first-page":"G991","DOI":"10.1152\/ajpgi.00298.2001","volume":"282","author":"HE Gonz\u00e1lez","year":"2002","unstructured":"Gonz\u00e1lez HE, Eugen\u00edn EA, Garc\u00e9s G, Sol\u00eds N, Pizarro M, Accatino L, et al. Regulation of hepatic connexins in cholestasis: possible involvement of Kupffer cells and inflammatory mediators. Am J Physiol Gastrointest Liver Physiol. 2002;282:G991\u20131001. https:\/\/doi.org\/10.1152\/ajpgi.00298.2001.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"7856_CR33","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1006\/cyto.1997.0287","volume":"10","author":"HV van Rijen","year":"1998","unstructured":"van Rijen HV, van Kempen MJ, Postma S, Jongsma HJ. Tumour necrosis factor alpha alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein endothelial cells. Cytokine. 1998;10:258\u201364. https:\/\/doi.org\/10.1006\/cyto.1997.0287.","journal-title":"Cytokine"},{"key":"7856_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000141012","volume":"112","author":"J-Y Li","year":"2009","unstructured":"Li J-Y, Lai Y-J, Yeh H-I, Chen C-L, Sun S, Wu S-J, et al. Atrial gap junctions, NF-kappaB and fibrosis in patients undergoing coronary artery bypass surgery: the relationship with postoperative atrial fibrillation. Cardiology. 2009;112:81\u20138. https:\/\/doi.org\/10.1159\/000141012.","journal-title":"Cardiology"},{"key":"7856_CR35","doi-asserted-by":"publisher","first-page":"e201901003","DOI":"10.1590\/s0102-865020190100000003","volume":"34","author":"AM Trevisan","year":"2019","unstructured":"Trevisan AM, Cogliati B, Homem AR, Aloiav TPA, de Aquino Neto N, Moreira JM, et al. The liver injury following ischemia and reperfusion is worse in experimental knockout heterozygote mouse model for expression of connexin 431. Acta Cir Bras. 2019;34:e201901003. https:\/\/doi.org\/10.1590\/s0102-865020190100000003.","journal-title":"Acta Cir Bras"},{"key":"7856_CR36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/jemt.20926","volume":"74","author":"B Cogliati","year":"2011","unstructured":"Cogliati B, Da Silva TC, Aloia TPA, Chaible LM, Real-Lima MA, Sanches DS, et al. Morphological and molecular pathology of CCL4-induced hepatic fibrosis in connexin43-deficient mice. Microsc Res Tech. 2011;74:421\u20139. https:\/\/doi.org\/10.1002\/jemt.20926.","journal-title":"Microsc Res Tech"},{"key":"7856_CR37","doi-asserted-by":"publisher","first-page":"100785","DOI":"10.1016\/j.lanepe.2023.100785","volume":"37","author":"M Vinciguerra","year":"2024","unstructured":"Vinciguerra M, Dobrev D, Nattel S. Atrial fibrillation: pathophysiology, genetic and epigenetic mechanisms. Lancet Reg Health Eur. 2024;37:100785. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100785.","journal-title":"Lancet Reg Health Eur"},{"key":"7856_CR38","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1053\/j.gastro.2004.06.047","volume":"127","author":"AP Feranchak","year":"2004","unstructured":"Feranchak AP, Doctor RB, Troetsch M, Brookman K, Johnson SM, Fitz JG. Calcium-dependent regulation of secretion in biliary epithelial cells: the role of apamin-sensitive SK channels. Gastroenterology. 2004;127:903\u201313. https:\/\/doi.org\/10.1053\/j.gastro.2004.06.047.","journal-title":"Gastroenterology"},{"key":"7856_CR39","doi-asserted-by":"publisher","first-page":"111401","DOI":"10.1016\/j.cellsig.2024.111401","volume":"124","author":"Y Chen","year":"2024","unstructured":"Chen Y, Bao L, Dong F, Xv M, Li W, Luo T, et al. Effect of fibroblasts small- conductance Ca2+ -activated potassium channel subtype 2 (SK2) on myocardial fibrosis in pressure overload mouse. Cell Signal. 2024;124:111401. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111401.","journal-title":"Cell Signal"},{"key":"7856_CR40","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/jamainternmed.2025.0115","volume":"185","author":"J Choi","year":"2025","unstructured":"Choi J, Nguyen VH, Przybyszewski E, Song J, Carroll A, Michta M, et al. Statin use and risk of hepatocellular carcinoma and liver fibrosis in chronic liver disease. JAMA Intern Med. 2025;185:522\u201330. https:\/\/doi.org\/10.1001\/jamainternmed.2025.0115.","journal-title":"JAMA Intern Med"},{"key":"7856_CR41","doi-asserted-by":"publisher","first-page":"103431","DOI":"10.1016\/j.eclinm.2025.103431","volume":"87","author":"A Suzuki","year":"2025","unstructured":"Suzuki A, Karachaliou GS, Perkins AM, Dorn C, Reeves RM, Arnold T, et al. Age-specific protective effects of Statins against cirrhosis in patients with chronic liver enzyme elevation associated with metabolic dysfunction: a retrospective cohort study of electronic health records. EClinicalMedicine. 2025;87:103431. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103431.","journal-title":"EClinicalMedicine"},{"key":"7856_CR42","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1111\/dom.16443","volume":"27","author":"J Wang","year":"2025","unstructured":"Wang J, Ding D, Shao X, Ma L, Xu J, Melehani J, et al. Antidiabetic and lipid-lowering medication use inversely linked with serum biomarkers of liver fibrosis. Diabetes Obes Metab. 2025;27:4148\u201356. https:\/\/doi.org\/10.1111\/dom.16443.","journal-title":"Diabetes Obes Metab"},{"key":"7856_CR43","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.jhep.2007.01.020","volume":"46","author":"JG Abraldes","year":"2007","unstructured":"Abraldes JG, Rodr\u00edguez-Vilarrupla A, Graupera M, Zafra C, Garc\u00eda-Calder\u00f3 H, Garc\u00eda-Pag\u00e1n JC, et al. Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats. J Hepatol. 2007;46:1040\u20136. https:\/\/doi.org\/10.1016\/j.jhep.2007.01.020.","journal-title":"J Hepatol"},{"key":"7856_CR44","doi-asserted-by":"publisher","first-page":"e18116","DOI":"10.1111\/jcmm.18116","volume":"28","author":"MA Elbaset","year":"2024","unstructured":"Elbaset MA, Mohamed BMSA, Hessin A, Abd El-Rahman SS, Esatbeyoglu T, Afifi SM, et al. Nrf2\/HO-1, NF-\u03baB and PI3K\/Akt signalling pathways Decipher the therapeutic mechanism of Pitavastatin in early phase liver fibrosis in rats. J Cell Mol Med. 2024;28:e18116. https:\/\/doi.org\/10.1111\/jcmm.18116.","journal-title":"J Cell Mol Med"},{"key":"7856_CR45","doi-asserted-by":"publisher","first-page":"118000","DOI":"10.1016\/j.biopha.2025.118000","volume":"186","author":"J Amer","year":"2025","unstructured":"Amer J, Salhab A, Safadi R. Rosuvastatin restores liver tissue-resident NK cell activation in aged mice by improving mitochondrial function. Biomed Pharmacother. 2025;186:118000. https:\/\/doi.org\/10.1016\/j.biopha.2025.118000.","journal-title":"Biomed Pharmacother"},{"key":"7856_CR46","doi-asserted-by":"publisher","first-page":"151094","DOI":"10.1016\/j.bbrc.2024.151094","volume":"742","author":"A-N Bae","year":"2025","unstructured":"Bae A-N, Lee H, Yang H, Mukherjee S, Im S-S, Lee J-H, et al. Enhancing regulatory T cell function by mevalonate pathway Inhibition prevents liver fibrosis. Biochem Biophys Res Commun. 2025;742:151094. https:\/\/doi.org\/10.1016\/j.bbrc.2024.151094.","journal-title":"Biochem Biophys Res Commun"},{"key":"7856_CR47","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jhep.2024.10.044","volume":"82","author":"HY Kim","year":"2025","unstructured":"Kim HY, Rosenthal SB, Liu X, Miciano C, Hou X, Miller M, et al. Multi-modal analysis of human hepatic stellate cells identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver disease. J Hepatol. 2025;82:882\u201397. https:\/\/doi.org\/10.1016\/j.jhep.2024.10.044.","journal-title":"J Hepatol"},{"key":"7856_CR48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12974-022-02433-x","volume":"19","author":"C Yi","year":"2022","unstructured":"Yi C, Liu J, Deng W, Luo C, Qi J, Chen M, et al. Macrophage elastase (MMP12) critically contributes to the development of subretinal fibrosis. J Neuroinflammation. 2022;19:78. https:\/\/doi.org\/10.1186\/s12974-022-02433-x.","journal-title":"J Neuroinflammation"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07856-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07856-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07856-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:21:44Z","timestamp":1771856504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07856-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7856"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07856-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The full study protocol was reviewed and approved by the Ethical Committee of The Fourth Hospital of Changsha (CSSDSYY-YXLL-SC-2025-03-16) and conformed to the principles of the Declaration of Helsinki. All patients provided informed consent for study participation and publication of anonymized data and images (proxies used where necessary).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"295"}}